Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
Top Cited Papers
- 23 May 2007
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (10) , 1617-1626
- https://doi.org/10.1007/s00259-007-0450-1
Abstract
Neuroendocrine tumours (NETs) can be imaged with scintigraphy using radiolabelled somatostatin analogues. The aim of our study was to compare the value of 68Ga-DOTATOC PET and 111In-DTPAOC SPECT (Octreoscan) in the detection of NET manifestations.Keywords
This publication has 22 references indexed in Scilit:
- Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Differential Expression of the Human Somatostatin Receptor Subtypes sst1 to sst5 in Various Adrenal Tumors and Normal Adrenal GlandHormone and Metabolic Research, 2005
- Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumoursActa Endocrinologica, 2004
- Expression of Somatostatin Receptor and Effects of Somatostatin Analog on Pancreatic Endocrine TumorsSurgery Today, 2002
- Expression of somatostatin receptor types 1–5 in 81 cases of gastrointestinal and pancreatic endocrine tumorsVirchows Archiv, 2002
- Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.Radiology, 1996
- Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes.Thorax, 1995
- Abdominal lymphadenopathy: spectrum of CT findings.RadioGraphics, 1991
- Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance.Radiology, 1988
- A new 68Ge/68Ga radioisotope generator system for production of 68Ga in dilute HClThe International Journal of Applied Radiation and Isotopes, 1981